ARCHIVES

FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate

This article is from The Cancer Letter archive.

Vol. 18 No. 33 | August 14, 1992

Download PDF Visit The Full Archive

Related Articles

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

March 28, 2014

Breast Cancer Plan Issues Its First RFA, Other Initiatives To Be Announced Soon

April 14, 1995

Research Suggestions Considered By DCBD Diagnostic Group

July 11, 1980

Diet and Cancer Risk Explored In Studies Presented At AACR Annual Meeting

April 30, 2004

John Niederhuber Named Acting NCI Director.

June 2, 2006

The NLST at a Glance

August 2, 2013